A developer of treatments for mental health disorders based on controlled hallucinogenic substances is raising $80 million in new venture financing. . . . → Read More: Psychiatric Drug Maker Raises $80M in Venture Funds
|
|||||
|
       
  |
 Comments are closed  Finance, New products  biomedical, clinical trials, entrepreneurs, equity, Europe, investment, life sciences, pharmaceuticals, psychiatric, U.K., venture capital 
A report on venture capital investments for the first quarter of 2020 shows biotechnology companies remain the largest recipients of venture investor dollars. . . . → Read More: Infographic – Biotech Remains Hottest Venture Sector Comments are closed Finance biotechnology, economics, equity, investment, statistics, venture capital 
The number of venture deals declined for the third straight quarter as 2020 opened, but biotechnology remained the hottest single sector for investors. . . . → Read More: Venture Deals Decline in Q1, Biotech Sizzles Again One comment - (Comments are closed) Finance Asia, biotechnology, economics, equity, Europe, investment, venture capital 
We check in from time to time on the Nasdaq Biotechnology Index as an indicator of the overall health of research-based businesses in the U.S. . . . → Read More: Infographic – Biotech Index Dives, Rebounds One comment - (Comments are closed) Finance biotechnology, Covid-19, economics, equity, investment, venture capital 
An industry group says rules for loans to small companies hard-hit by Covid-19 are changed to allow these loans for more start-ups funded by venture capital. . . . → Read More: Venture-Backed Start-Ups to Get Small Biz Loans Comments are closed Finance, Regulations Covid-19, debt, economics, entrepreneurs, equity, investment, venture capital 
Two investment companies specializing in health care and life sciences revealed new venture funds to finance young enterprises with innovative technologies. . . . → Read More: Life Science Venture Funds Raise $2.56B for Start-Ups 2 comments - (Comments are closed) Finance biomedical, biotechnology, entrepreneurs, equity, investment, life sciences, mathematics, medical device, pharmaceuticals, physical sciences, venture capital 
A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license its technology to a pharmaceutical company. . . . → Read More: Start-Up Licenses Immunotherapies in $880M Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, U.K., university, venture capital 
A life science incubator company plans to fund eight start-up enterprises developing diagnostics, vaccines, or treatments for the Covid-19 pandemic. . . . → Read More: Venture Fund to Back Covid-19 Start-Ups One comment - (Comments are closed) Finance biomedical, biotechnology, Covid-19, engineering, entrepreneurs, equity, investment, life sciences, medical device, pharmaceuticals, venture capital 
A developer of genetically-modified bacteria designed to work in the gut is raising $2.3 million more in seed funds to expand its product line. . . . → Read More: Engineered Probiotic Maker Gains $2.3M Seed Funding Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, preclinical, venture capital 
The developer of a patch device that monitors and adjusts heart rhythms to prevent sudden cardiac death is raising $145.6 million in a new venture funds. . . . → Read More: Wearable Defibrillator Maker Gains $145.6M Comments are closed Finance, New products biomedical, engineering, entrepreneurs, equity, heart disease, investment, life sciences, mathematics, medical device, software, venture capital |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||